Feto-maternal distribution of ropivacaine and bupivacaine after epidural administration for cesarean section
- 1 July 1997
- journal article
- clinical trial
- Published by Elsevier in International Journal of Obstetric Anesthesia
- Vol. 6 (3) , 147-152
- https://doi.org/10.1016/s0959-289x(97)80078-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Transfer of Lidocaine and Bupivacaine Across the Isolated Perfused Human Placenta *Basic & Clinical Pharmacology & Toxicology, 1995
- The Effects of Epidural Ropivacaine and Bupivacaine for Cesarean Section on Uteroplacental and Fetal CirculationAnesthesiology, 1995
- Transfer and Uptake of Alfentanil in the Human Placenta During In Vitro PerfusionAnesthesia & Analgesia, 1994
- A New Local Anesthetic, RopivacaineAnesthesia & Analgesia, 1990
- Pharmacodynamics and Pharmacokinetics of Epidural Ropivacaine in HumansAnesthesia & Analgesia, 1989
- Cardiotoxicity of ropivacaine – a new amide local anaesthetic agentActa Anaesthesiologica Scandinavica, 1989
- Comparative Pharmacokinetics of Bupivacaine and Ropivacaine, a New Amide Local AnestheticAnesthesia & Analgesia, 1988
- Comparative Motor-Blocking Effects of Bupivacaine and Ropivacaine, A New Amino Amide Local Anesthetic, in the Rat and DogAnesthesia & Analgesia, 1988
- Primary evaluation of the local anaesthetic properties of the amino amide agent ropivacaine (LEA 103)Acta Anaesthesiologica Scandinavica, 1988
- ABSORPTION OF BUPIVACAINE, ETIDOCAINE, LIGNOCAINE AND ROPIVACAINE INTO N-HEPTANE, RAT SCIATIC NERVE, AND HUMAN EXTRADURAL AND SUBCUTANEOUS FATBritish Journal of Anaesthesia, 1986